Catheter Precision Business Summary

Catheter Precision, Inc. (VTAK) is a medical technology company specializing in the cardiac electrophysiology (EP) market, primarily generating revenue through the direct sale of proprietary hardware and disposable medical devices. The company’s business model is centered on two core product segments: the VIVO (View into Ventricular Onset) system, a non-invasive 3D imaging platform that maps ventricular arrhythmias prior to clinical procedures, and the LockeT suture retention device, designed to streamline workflow and improve patient recovery following venous catheter access. As of early 2026, the company has aggressively expanded its commercial footprint into European and African markets, supported by a 100% product-based revenue stream and a high-margin consumables model. Catheter Precision competes directly with specialized medical device firms such as ENvue Medical (FEED), Intelligent Bio Solutions (INBS), and STRATA Skin Sciences (SSKN), positioning itself as a niche innovator providing cost-effective, non-invasive alternatives to the complex mapping systems offered by industry giants like Medtronic and Boston Scientific. The company is led by Founder, CEO, and Executive Chairman David Jenkins, a veteran executive with over 30 years of experience in the medical device sector who previously served as CEO of EP MedSystems and Arrhythmia Research Technology. The executive team includes Chief Financial Officer Philip Anderson, who brings a background in small-cap finance and hedge fund management, and Chief Commercial Officer Marie-Claude Jacques, a former executive at Boston Scientific and Baylis Medical. The leadership is supported by a board of directors featuring industry experts such as Martin Colombatto, Andrew Arno, and James Caruso. Notable institutional backing includes FatBoy Capital (controlled by Jenkins), Armistice Capital, and Vanguard Group, with the company recently securing a $36.5 million strategic financing round in February 2026 to accelerate its global commercialization efforts.